Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells.

The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells. Leuk Lymphoma. 2008 Aug; 49(8):1567-77.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.